ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS)

CUSIP: 76090R309

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
3,326,711
Total 13F shares
19,112
Share change
+17,848
Total reported value
$85,238
Price per share
$4.46
Number of holders
9
Value change
+$79,600
Number of buys
4
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 76090R309?
CUSIP 76090R309 identifies RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) as of Q4 2024

As of 31 Dec 2024, ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,112 shares. The largest 9 holders included UBS Group AG, Tower Research Capital LLC (TRC), BlackRock, Inc., BANK OF AMERICA CORP /DE/, GROUP ONE TRADING LLC, OSAIC HOLDINGS, INC., SBI Securities Co., Ltd., CIBC Private Wealth Group LLC, and MORGAN STANLEY. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.